Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | VB10.16 |
| Trade Name | |
| Synonyms | DNA Vaccine VB10.16 |
| Drug Descriptions |
VB10.16 is a DNA vaccine comprised of inactivated HPV16 E6 and E7 proteins attached to the chemokine macrophage inflammatory protein-1 alpha (MIP-1alpha), which may lead to activation of immune response and tumor cell lysis (Annals of Oncology 31 (2020): S645-S646; NCI Drug Dictionary). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C123923 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Atezolizumab + VB10.16 | Atezolizumab VB10.16 | 0 | 2 |
| Pembrolizumab + VB10.16 | Pembrolizumab VB10.16 | 0 | 1 |
| VB10.16 | VB10.16 | 0 | 1 |